These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Studies on the oral administration of live attenuated poliovirus vaccine in the monkey]. KAMBARA Y. Virus; 1961 Oct; 11():333-49. PubMed ID: 14453401 [No Abstract] [Full Text] [Related]
8. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine. JUNGHERR EL, CABASSO VJ, MOYER AW, COX HR. J Infect Dis; 1961 Oct; 108():247-61. PubMed ID: 13791071 [No Abstract] [Full Text] [Related]
9. Interference patterns encountered when using attenuated poliovirus vaccines. HALE JH, LEE LH, GARDNER PS. Br Med J; 1961 Sep 16; 2(5254):728-32. PubMed ID: 13710702 [No Abstract] [Full Text] [Related]
10. Response of Cuban children to oral vaccination with living attenuated poliovirus vaccines. A clinical and serological study. EMBIL J. Br Med J; 1960 Apr 16; 1(5180):1157-62. PubMed ID: 13820150 [No Abstract] [Full Text] [Related]
13. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses. EGGERS HJ, SABIN AB. Arch Gesamte Virusforsch; 1961 Apr 16; 11():152-75. PubMed ID: 13725917 [No Abstract] [Full Text] [Related]
16. Attenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population. HORSTMANN DM, NIEDERMAN JC, PAUL JR. J Am Med Assoc; 1959 May 02; 170(1):1-8. PubMed ID: 13640973 [No Abstract] [Full Text] [Related]
17. IN VITRO MARKER OF POLIOVIRUSES OBTAINED FROM HUMAN STOOLS AFTER ADMINISTRATION OF ATTENUATED LIVE POLIOVIRUS VACCINE (SABIN). KASAHARA S, YOSHIOKA I, YAMAGISHI H, AIZAWA C. Kitasato Arch Exp Med; 1963 Dec 02; 36():77-86. PubMed ID: 14318783 [No Abstract] [Full Text] [Related]
19. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES]. UNTERHARNSCHEIDT F, BONIN O. Arch Psychiatr Nervenkr; 1965 Mar 01; 206():454-73. PubMed ID: 14271779 [No Abstract] [Full Text] [Related]
20. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus. VAN HOOSIER GL, BARON S, KIRSCHSTEIN RL, ABINANTI FR. Am J Hyg; 1962 Jan 01; 75():86-9. PubMed ID: 13924586 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]